Reckitt CEO's $17B Predicament Post author:Sam Post published:December 26, 2017 Post category:BioPharma 2018 is the year for Rakesh Kapoor to show he’s worth it. Source: BioSpace You Might Also Like <b>Teresa L. Kline</b> Joins Intersect ENT???s Board Of Directors July 20, 2017 Israeli Medtech Startup Raises $8 Million February 8, 2017 Regeneron to Terminate Its Antibody Discovery Pact With Sanofi August 2, 2017
